Reported 55,000,000 shares, down 15,000,000 (21.4%) from the prior quarter.
Reported value -31.4%; share count -21.4% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2026-03-31 | 126632940 |
| 2026-06-30 | 124775000 |
| 2026-09-30 | 85582310 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q3 2026 | Reduced | 55,000,000 | -15,000,000 (-21.4%) | 5.29% | $85,582,310 | 2026-11-13 | |
| Q2 2026 | Unchanged | 70,000,000 | 0 (0.0%) | 8.9% | $124,775,000 | 2026-08-14 | |
| Q1 2026 | New | 70,000,000 | +70,000,000 (0.0%) | 9.1% | $126,632,940 | 2026-05-13 |
Who else reported the position
45 managers reported BRIDGEBIO PHARMA INC for Q3 2026.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| AMUNDI | Unchanged | 2,300,000 | 0 | 0.07% | $355,465,000 | 8 qtrs |
| WOLVERINE ASSET MANAGEMENT LLC | Unchanged | 0 | 0 | 1.21% | $180,289,564 | 12 qtrs |
| CAPSTONE INVESTMENT ADVISORS LLC | Added | 104,888,000 | +35,016,000 | 0.24% | $162,628,844 | 5 qtrs |
| DeepCurrents Investment Group LLC | Added | 57,745,000 | +7,500,000 | 2.58% | $89,834,485 | 3 qtrs |
| STEELHEAD PARTNERS LLC This report | Reduced | 55,000,000 | -15,000,000 | 5.29% | $85,582,310 | 3 qtrs |
| ExodusPoint Capital Management LP | New | 45,500,000 | +45,500,000 | 0.37% | $70,850,489 | 1 qtr |
| BOUSSARD & GAVAUDAN GESTION SAS | Added | 35,000 | +6,000 | 4.27% | $55,199,638 | 2 qtrs |
| Bank of America Corporation | Added | 30,777,000 | +17,767,000 | < 0.01% | $47,565,854 | 10 qtrs |
| Graham Capital Management L P | Unchanged | 22,241,000 | 0 | 0.51% | $34,588,727 | 13 qtrs |
| TENOR CAPITAL MANAGEMENT Co L P | New | 16,500,000 | +16,500,000 | 0.32% | $25,683,494 | 7 qtrs |
Filing details and methodology As reported
- Report period
- September 30, 2026
- Filed
- November 13, 2026
- Filing type
- 13F-HR
- Position type
- NOTE 2.500% 3/1
Voting authority reported
- Sole
- 55,000,000
- Shared
- 0
- None
- 0
“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.